EUVIMEDEUVIMED entdecken
Crossref

Heterostructure Nanozyme with Hyperthermia‐Amplified Enzyme‐Like Activity and Controlled Silver Release for Synergistic Antibacterial Therapy

Meng Zhang, Wenhui Yue, Weishuai Ma, Xiaoning Wang, Yuanhong Xu iD, Aihua Li

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202401602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Meng Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, College of Life Science, Qingdao University, Qingdao, 266071, P. R. China. Hauptthemen laut MEDLINE: Silver, Anti-Bacterial Agents, Metal Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation for Distinguished Young Scholars of Shandong Province, Taishan Scholar Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterostructure nanozymes as antibiotic‐free antimicrobial agents exhibit great potential for multidrug‐resistant (MDR) bacterial strains elimination. However, realization of heterostructure antimicrobials with enhanced interfacial interaction for synergistically amplified antibacterial therapy is still a great challenge. Herein, oxygen‐vacancy‐enriched glucose modified MoO x (G‐MoO x ) is exploited as a reducing agent to spontaneously reduce Ag (I) into Ag (0) that in situ grows onto the surface of G‐MoO x . The resultant Ag doped G‐MoO x (Ag/G‐MoO x ) heterostructure displays augmenting photothermal effect and NIR‐enhanced oxidase‐like activity after introducing Ag nanoparticles. What's more, NIR hyperthermia accelerate Ag + ions release from Ag nanoparticles. Introduction of Ag greatly enhances antimicrobial activities of Ag/G‐MoO x against MDR bacteria, especially the hybrid loading with 1 wt% Ag NPs exhibiting antibacterial efficacy up to 99.99% against Methicillin‐resistant Staphylococcus aureus (MRSA, 1×10 6 CFU mL −1 ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SilverAnti-Bacterial AgentsMetal NanoparticlesMethicillin-Resistant Staphylococcus aureusHyperthermia, InducedMicrobial Sensitivity TestsHumansDelayed-Action Preparations

Stichwörter der Autor:innen

Ag nanoparticlesMoOx nanozymemultidrug‐resistant bacteriaoxidase‐like activityphotothermal effect

Substanzen

SilverAnti-Bacterial AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Institute of Biomedical Engineering, College of Life Science, Qingdao University, Qingdao, 266071, P. R. China.
  • College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, P. R. China.

ORCID-Profile: Yuanhong Xu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation for Distinguished Young Scholars of Shandong Province
  • Taishan Scholar Foundation of Shandong Province

Zitieren

APA

Zhang, M., Yue, W., Ma, W., Wang, X., Xu, Y., & Li, A. (2025). Heterostructure Nanozyme with Hyperthermia‐Amplified Enzyme‐Like Activity and Controlled Silver Release for Synergistic Antibacterial Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401602

Vancouver

Zhang M, Yue W, Ma W, Wang X, Xu Y, Li A. Heterostructure Nanozyme with Hyperthermia‐Amplified Enzyme‐Like Activity and Controlled Silver Release for Synergistic Antibacterial Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202401602

BibTeX
@article{Zhang2025,
  author = {Zhang, Meng and Yue, Wenhui and Ma, Weishuai and Wang, Xiaoning and Xu, Yuanhong and Li, Aihua},
  title = {Heterostructure Nanozyme with Hyperthermia‐Amplified Enzyme‐Like Activity and Controlled Silver Release for Synergistic Antibacterial Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202401602}
}
Kostenlos starten →